HOME >> BIOLOGY >> NEWS
Premies' Lung Disorder Can Cause Developmental Delays

Babies weighing as little as 1-1/2 pounds would not have survived a generation ago, but through recent technological advances, most of these children are able to live today. However, some of that life-giving technology is also exacting a price on the kids, according to a new study published in the December issue of the medical journal Pediatrics.

Investigators from Case Western Reserve University's School of Medicine found that a significant percentage of very low birth weight babies sustain long-term cognitive and motor developmental problems if they suffer from the lung disease called bronchopulmonary dysplasia (BPD).

Very small premature infants have a high chance of having BPD because it is caused by prolonged exposure to mechanical ventilation, which premies need because of underdeveloped lungs. BPD is now the leading cause of lung disease in U.S. infants and the third leading cause of chronic lung disease in children.

The study found that by 3 years of age, about 21 percent of infants with BPD tested in the range of retardation, compared to less than 10 percent of very low birth weight babies without BPD, and less than 3 percent of term babies.

"We found that independent of any other complications of prematurity, kids at 3 years of age who had BPD as infants who had been premature had some motor problems that were associated with BPD, " said Lynn Singer, the study's lead author and a professor of pediatrics. "Motor problems included things like balance, holding crayons and pencils, and eye-hand coordination."

On the other hand, said Singer, "In terms of their language and mental development, BPD was not related to any additional problems for them at 3 years of age. However, because BPD babies were smaller and sicker, they had higher rates of delay at 3 years."

Singer said that BPD may be a factor in the higher rates of learning disabilities that pre-term babies experience at school age.

The study exami
'"/>

Contact: George Stamatis
gxs18@po.cwru.edu
216-368-3635
Case Western Reserve University
9-Dec-1997


Page: 1 2 3

Related biology news :

1. Gene mutation in rare familial form of Obsessive-Compulsive Disorder (OCD)
2. NIMH awards $22.6 million for Center for Collaborative Research on Mental Disorders
3. Disorder forces DNA molecules out of tight spaces
4. Protein Misfolding, Not Mutant Gene, Key To Lethal Sleep Disorder
5. UF Researcher: Athletes Likely To Have Symptoms Of Eating Disorders
6. Oregon Scientists Discover A Second Blood-Brain Barrier; Important Finding For Patients With Brain Cancers And Neurological Disorders
7. Variations In The Human Homologue Of A Fruit Fly Gene Are Associated With Mood And Panic Disorders
8. Serotonin May Be Better Target For Attention Deficit Hyperactivity Disorder Treatment
9. Duke Study Shows Umbilical Cord Blood Transplant Is Viable Treatment For Genetic Disorders
10. Williams Syndrome: UD Research Pinpoints Language And Learning Traits Of Those With The Disorder
11. Tau Gene Linked To Family Of Neurodegenerative Disorders; Finding May Yield Insight Into Onset Of Alzheimers Disease

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Premies Lung Disorder Can Cause Developmental Delays

(Date:2/5/2015)... 2015 Despite a lack of advancements ... as consumer electronics, automotive, storage and telecommunication has ... (SMT) screen printers. Innovations in electronics and conversion ... the adoption curve up. Meanwhile, sale volumes of ... dispensers are indispensable in the production of complex ...
(Date:1/22/2015)... 2015 /PRNewswire/ - Today, FindBiometrics, the leading source of biometrics industry ... new website design. "When we launched FindBiometrics 12 ... Peter O,Neill , founder and CEO of FindBiometrics. "Now it,s ... from the key players on a very broad scale.  We ...
(Date:1/22/2015)... , Jan. 15, 2015  BellBrook Labs, a ... discovery, announced the launch of a TR-FRET (time ... company,s Transcreener UDP Assay, a high throughput screening ... new assay will allow for sensitive detection of ...
Breaking Biology News(10 mins):End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2
(Date:3/3/2015)... , March 3, 2015 Fried, Frank, Harris, ... I.D. Lewis has joined the Firm as a ... the New York office. Mr. ... matters, as well as other intellectual property and general ... Mr. Lewis represents both plaintiffs and defendants in a ...
(Date:3/3/2015)... , March 3, 2015  RegeneRx Biopharmaceuticals, Inc. ... in the scientific journal, Expert Opinion on Biological ... colleague, Dr. Zhenggang Zhang , at the Henry ... reported that Thymosin beta 4 (TB4) has the capacity ... 24 hours or more post-injury, leading to neurological recovery ...
(Date:3/3/2015)... AtheroNova Inc. (OTCQB: AHRO) today announced that the ... under Chapter 11 of the U.S. Bankruptcy Code in the ... , Santa Ana division (the "Bankruptcy ... are expected to be jointly administered. The Company ... sale process, for all or substantially all of its assets ...
(Date:3/3/2015)... Switzerland (PRWEB) March 03, 2015 ... for drug discovery and life science research, today ... Biologics (TM) enterprise platform for use at Pfizer ... and Europe. Genedata is supporting Pfizer’s global deployment ... Technologies (GBT), Centers for Therapeutic Innovation (CTI), and ...
Breaking Biology Technology:Leading Patent Attorney Jeffrey Lewis Joins Fried Frank's Intellectual Property Litigation Practice 2Leading Patent Attorney Jeffrey Lewis Joins Fried Frank's Intellectual Property Litigation Practice 3Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 2Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 3AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 2AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 3AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 4Genedata Biologics Licensed by Pfizer Inc. 2Genedata Biologics Licensed by Pfizer Inc. 3
Cached News: